Status:
COMPLETED
Mouth Handicap in Systemic Sclerosis
Lead Sponsor:
Istanbul University
Collaborating Sponsors:
Istanbul University - Cerrahpasa
Conditions:
Scleroderma
Systemic Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, it is aimed to investigate the mouth handicap in Systemic Sclerosis.
Detailed Description
Systemic Sclerosis is an autoimmune connective tissue disease with fibrosis. Although its etiology and pathogenesis have not been clearly defined, it has a chronic course. Systemic sclerosis is estima...
Eligibility Criteria
Inclusion
- To be diagnosed with systemic sclerosis
- Stability of medical treatments
- Turkish literacy
Exclusion
- The patient has a history of neurological disease or trauma that may affect his symptoms
- Oral treatment for the last 6 months
- Being in active phase of the disease
- Skin infection and presence of open wound
- Having used dental orthosis in the last month
- Disorder of cognition or cooperation
Key Trial Info
Start Date :
December 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2022
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04273386
Start Date
December 2 2019
End Date
March 20 2022
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye)